AI assistant
Sending…
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017
Sep 15, 2017
29864_dirs_2017-09-15_a8190b30-6d7f-401c-8995-c722758d43ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-09-13
Reporting Person: Graney Thomas (Chief Financial Officer)
More from VERTEX PHARMACEUTICALS INC / MA
Major Shareholding Notification
2026
May 14
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13